Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Oct;41(4):336-40.

An open study of clozapine in the treatment of resistant schizophrenia

N Desai  1 , V Jain, S Ghalsasi, M Dalvi, S Kelkar
Affiliations

An open study of clozapine in the treatment of resistant schizophrenia

N Desai et al. Indian J Psychiatry. 1999 Oct.

Abstract

This open study was undertaken to assess the efficacy of clozapine in resistant schizophrenics, its side effects and safety profile and the mean dose required. Sample consisted of 28 patients who had been previously treated with neuroleptics and ECTs. A special proforma was prepared for recording the psychopathology and side effect profile. The complete blood count, differential count and BPRS scores were recorded weekly for a period of 3 months. Within 1 month of treatment on a dose range of 100-200 mg/day a 25%-50% decline in the BPRS score was noticed, the mean dose required was 241 mg/day. Sedation and sialorrhoea constituted the commonest side effects in 90% patients. No case of agranulocytosis was reported. The implications of the study are discussed.

Keywords: Clozapine; treatment resistant schizophrenia.

PubMed Disclaimer

References

    1. Hosp Community Psychiatry. 1993 Dec;44(12):1145-9 - PubMed
    1. Eur J Clin Pharmacol. 1977 Mar 11;11(3):199-201 - PubMed
    1. Br J Psychiatry Suppl. 1992 May;(17):41-5 - PubMed
    1. Drugs. 1993 Oct;46(4):585-93 - PubMed
    1. J Clin Psychiatry. 1989 Oct;50(10):389-91 - PubMed